Melinda Astran, MD
Family Practice · Sacramento
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 29 years
- University of Texas Medical Branch at Galveston, 1997
Offices
1 location · Peach Tree Healthcare · 32 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Astran’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence C163169 · Current
Licensed to practise in California · since 2019 · expires 2027-06-30 · University of Texas Medical Branch at Galveston.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
2 licences
- Texas K7650Physician License · since 1999 · expires 2028-08-31ActiveNo board action on this licenceCheck it with the state
- Florida ME88278Medical Doctor · since 2003 · expires 2011-01-31Null And VoidNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
School, training and certification
1 placement
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- Family Medicinecertified 2000
- American Board of Family Medicine - Family Medicine
Education
- Univer of Texas Galveston Tx · MD1997Medical school
Residency and fellowship
- Central Texas Medical Foundation, Family MedicineAUSTIN, TX · 1997–2000
What else the board holds
Hospitals they may admit to
Where the clinician told their state board they may admit and treat patients.
- Leesburg Regional Medical Center · FL
Also licensed in
States the clinician told their board they are also licensed in. Only the states we check are verified.
Texas · Virgin Islands
Original Medicare doctor bills
$6,627
Medicare paid this office $6,627 for 55 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 34 | $3,946 | $101 |
| Short return visit (20+ min) | 12 | $860 | $72 |
Who their Medicare patients are
55 Original Medicare patients in 2024. Average age 70 · Women 69% · Also on Medicaid 27% · Health risk score 0.73. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 65% · Coronary heart disease 22% · Depression 22%.
The office billed $28,737, Medicare allowed $8,984 and paid $6,627; for 72 services of 7 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 55 | 72 | 70 | 0.73 | $28,737 | $6,627 |
| 2015 | 49 | 70 | 69 | 2.40 | $5,386 | $2,789 |
| 2014 | 48 | 93 | 69 | 1.91 | $6,945 | $4,688 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2015: 2 services
| Return visit (30+ min) | 27 | $1,896 | $45 |
| Short return visit (20+ min) | 18 | $622 | $35 |
2014: 2 services
| Return visit (30+ min) | 36 | $3,333 | $61 |
| Short return visit (20+ min) | 21 | $1,206 | $40 |
Medicaid work
$210,184 in 2024
Medicaid paid $210,184 for 2,988 billed services this clinician did in 2024, up to 201 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,042 | $209,716 |
| Short return visit (20+ min) | 1,218 | $193 |
| Return visit (30+ min) | 246 | $187 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 13 | $64 |
| Screening for depression is documented as negative, a follow-up plan is not required | 194 | $21 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 13 | $2 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 42 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 63 | $0 |
| HEMOGLOBIN | 25 | $0 |
| Pure tone audiometry (threshold); air only | 13 | $0 |
| Bilateral quantitative screening test of visual acuity | 18 | $0 |
| Short return visit | 68 | $0 |
| 2024 | 2,988 | 13 | 201 | $210,184 |
| 2023 | 2,630 | 11 | 122 | $142,025 |
| 2022 | 1,723 | 11 | 151 | $52,047 |
| 2021 | 720 | 5 | 43 | $167,280 |
| 2020 | 674 | 6 | 32 | $186,933 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 908 | $140,661 |
| Short return visit (20+ min) | 627 | $655 |
| Short return visit | 506 | $442 |
| Return visit (30+ min) | 184 | $169 |
| BLOOD PRESSURE MEASURED | 106 | $76 |
| Handling and/or conveyance of specimen for transfer from physician office to laboratory | 86 | $23 |
| WEIGHT RECORDED | 48 | $0 |
| VITAL SIGNS RECORDED | 70 | $0 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 57 | $0 |
| New patient visit (30+ min) | 12 | $0 |
| Screening for depression is documented as negative, a follow-up plan is not required | 26 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 271 | $51,897 |
| Short return visit (20+ min) | 161 | $119 |
| Short return visit | 115 | $31 |
| Screening for depression is documented as negative, a follow-up plan is not required | 386 | $0 |
| Medication list documented in medical record (COA) | 438 | $0 |
| BODY MASS INDEX DOCD | 80 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 16 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 16 | $0 |
| Return visit (30+ min) | 113 | $0 |
| Exercise classes, non-physician provider, per session | 63 | $0 |
| Nutrition classes, non-physician provider, per session | 64 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 322 | $160,135 |
| Return visit (30+ min) | 107 | $4,812 |
| Short return visit (20+ min) | 119 | $2,333 |
| Annual depression screening, 5 to 15 minutes | 93 | $0 |
| Screening for depression is documented as negative, a follow-up plan is not required | 79 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 360 | $162,695 |
| Return visit (30+ min) | 77 | $15,577 |
| Short return visit (20+ min) | 87 | $8,316 |
| Short return visit | 46 | $346 |
| Annual depression screening, 5 to 15 minutes | 90 | $0 |
| Screening for depression is documented as negative, a follow-up plan is not required | 14 | $0 |
Drugs they prescribed that Part D paid
$109,793
Pharmacies billed $109,793 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 845) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.
658 generic and 174 brand-name prescriptions · $109,793 in drug cost · 17 antibiotic prescriptions to 17 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 42 | $31,472 | $749 |
| Ozempic | 18 | $16,647 | $925 |
| Albuterol Sulfate Hfa | 11 | $437 | $40 |
| Atorvastatin | 70 | $410 | $6 |
| Rosuvastatin | 21 | $347 | $17 |
See all 18 drugs
| Jardiance | 42 | $31,472 | $749 |
| Ozempic | 18 | $16,647 | $925 |
| Albuterol Sulfate Hfa | 11 | $437 | $40 |
| Atorvastatin | 70 | $410 | $6 |
| Rosuvastatin | 21 | $347 | $17 |
| Metoprolol | 21 | $336 | $16 |
| Levothyroxine | 58 | $329 | $6 |
| Fluticasone Propionate | 20 | $226 | $11 |
| Lisinopril | 66 | $213 | $3 |
| Metformin | 57 | $202 | $4 |
| Gabapentin | 12 | $121 | $10 |
| Omeprazole | 24 | $116 | $5 |
| Losartan | 20 | $114 | $6 |
| Famotidine | 12 | $64 | $5 |
| Amlodipine Besylate | 27 | $52 | $2 |
| Metformin Hcl Er | 12 | $50 | $4 |
| Meloxicam | 14 | $49 | $4 |
| Simvastatin | 17 | $38 | $2 |
Year by year
| 2024 | 845 | 136 | 0% (0) | 21% | $109,793 |
| 2023 | 116 | 48 | 0% (0) | None | $25,079 |
| 2022 | 135 | 36 | 0% (0) | 10% | $12,150 |
| 2021 | 767 | 148 | None | 20% | $79,020 |
| 2020 | 741 | 135 | None | 17% | $64,497 |
| 2019 | 16 | None | 0% (0) | None | $1,173 |
| 2016 | 11 | None | None | None | $177 |
| 2015 | 394 | 27 | None | 29% | $40,973 |
| 2014 | 711 | 50 | 2% (15) | 26% | $66,899 |
| 2013 | 690 | 58 | 3% (20) | None | $41,652 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 2 drugs
| Fluticasone Propionate | 12 | $137 | $11 |
| Atorvastatin | 14 | $129 | $9 |
2021: 20 drugs
| Victoza 3-Pak | 13 | $13,084 | $1,006 |
| Xigduo Xr | 11 | $10,728 | $975 |
| Lantus Solostar | 11 | $3,966 | $361 |
| Levothyroxine | 41 | $936 | $23 |
| Fluticasone Propionate | 33 | $812 | $25 |
| Albuterol Sulfate Hfa | 13 | $680 | $52 |
| Ultra-Fine Mini Pen Needle | 12 | $611 | $51 |
| Atorvastatin | 54 | $557 | $10 |
| Lisinopril | 79 | $419 | $5 |
| Tamsulosin | 18 | $405 | $23 |
| Sertraline | 15 | $318 | $21 |
| Omeprazole | 18 | $301 | $17 |
| Losartan | 25 | $140 | $6 |
| Amlodipine Besylate | 41 | $125 | $3 |
| Simvastatin | 25 | $117 | $5 |
| Metformin | 20 | $113 | $6 |
| Clopidogrel | 14 | $79 | $6 |
| Metformin Hcl Er | 15 | $73 | $5 |
| Meloxicam | 12 | $46 | $4 |
| Hydrochlorothiazide | 18 | $39 | $2 |
2020: 13 drugs
| Levothyroxine | 38 | $901 | $24 |
| Fluticasone Propionate | 26 | $476 | $18 |
| Atorvastatin | 54 | $405 | $7 |
| Lisinopril | 80 | $319 | $4 |
| Nitroglycerin | 12 | $170 | $14 |
| Clopidogrel | 16 | $138 | $9 |
| Alendronate | 20 | $124 | $6 |
| Tamsulosin | 14 | $123 | $9 |
| Metformin | 19 | $82 | $4 |
| Losartan | 17 | $82 | $5 |
| Amlodipine Besylate | 29 | $77 | $3 |
| Simvastatin | 20 | $75 | $4 |
| Hydrochlorothiazide | 13 | $61 | $5 |
2015: 11 drugs
| Levemir | 16 | $14,859 | $929 |
| Novolog | 16 | $8,818 | $551 |
| Insulin | 24 | $675 | $28 |
| Montelukast | 11 | $664 | $60 |
| Amlodipine Besylate | 15 | $578 | $39 |
| Omeprazole | 32 | $361 | $11 |
| Levothyroxine | 22 | $349 | $16 |
| Gabapentin | 13 | $175 | $13 |
| Lisinopril | 23 | $132 | $6 |
| Simvastatin | 29 | $110 | $4 |
| Furosemide | 14 | $65 | $5 |
2014: 23 drugs
| Levemir | 28 | $17,749 | $634 |
| Novolog | 26 | $11,969 | $460 |
| Abilify | 11 | $8,965 | $815 |
| Lantus | 12 | $6,812 | $568 |
| Divalproex Sodium Er | 12 | $3,146 | $262 |
| Amlodipine Besylate | 37 | $1,505 | $41 |
| Montelukast | 13 | $1,142 | $88 |
| Omeprazole | 47 | $1,069 | $23 |
| Insulin | 30 | $879 | $29 |
| Bupropion Xl | 12 | $849 | $71 |
| Fenofibrate | 15 | $651 | $43 |
| Levothyroxine | 25 | $371 | $15 |
| Lisinopril | 50 | $351 | $7 |
| Clopidogrel | 20 | $312 | $16 |
| Fluticasone Propionate | 11 | $257 | $23 |
| Losartan | 25 | $242 | $10 |
| Simvastatin | 47 | $209 | $4 |
| Naproxen | 11 | $138 | $13 |
| Metformin | 12 | $123 | $10 |
| Atenolol | 23 | $116 | $5 |
| Glipizide Er | 11 | $101 | $9 |
| Lanoxin | 12 | $97 | $8 |
| Furosemide | 12 | $62 | $5 |
2013: 20 drugs
| Abilify | 11 | $7,270 | $661 |
| Novolog | 12 | $5,270 | $439 |
| Levemir | 17 | $4,975 | $293 |
| Omeprazole | 38 | $1,083 | $28 |
| Bupropion Xl | 11 | $689 | $63 |
| Amlodipine Besylate | 23 | $685 | $30 |
| Fluticasone Propionate | 17 | $563 | $33 |
| Lactulose | 15 | $481 | $32 |
| Lisinopril | 42 | $400 | $10 |
| Glipizide Er | 23 | $352 | $15 |
| Metoprolol | 11 | $351 | $32 |
| Diltiazem Er | 12 | $309 | $26 |
| Simvastatin | 60 | $291 | $5 |
| Losartan | 25 | $283 | $11 |
| Levothyroxine | 20 | $261 | $13 |
| Metformin | 21 | $228 | $11 |
| Clopidogrel | 16 | $221 | $14 |
| Naproxen | 15 | $214 | $14 |
| Furosemide | 19 | $103 | $5 |
| Atenolol | 13 | $81 | $6 |
Money from drug and device companies
$30 in 2021
A payment is not proof that care is biased.
| Daiichi Sankyo | Injectafer | $30 | 1 payment
|
See the published payment
| Daiichi Sankyo | Meals · 2021-06-29 | Injectafer | $30 |
Professional record
- NPI
- 1184624744
- Licence
- AZ 34058, CA C163169, FL ME88278, TX K7650California C163169: Current · expires 2027-06-30Texas K7650: ActiveFlorida ME88278: Null And Void
- Trained
- University of Texas Medical Branch at Galveston, 1997 · 29 years ago
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- AZ 970089
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 1114 Yuba St Ste 220, Marysville, CA, 95901
- NPI first listed
- 2005-07-26
- NPI last updated
- 2025-04-10
- NPI record certified
- 2025-04-10
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 4058 Willows Rd, Alpine, CA, 91901 · 36350 Church Rd, Campo, CA, 91906